FDA Approves Wegovy to Help Prevent Heart Attack, Stroke
FRIDAY, March 8, 2024 (HealthDay News) — Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death. “Wegovy is now the first weight-loss medication to also be approved to helpContinue Reading